Lynbrook, NY, United States of America

Biospecifics Technologies Corporation


USPTO Granted Patents = 6



Forward Citations = 8

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Thomas L Wegman (6 out of 10 patents)

silverMedal Phyllis Carolyn Leppert (4 out of 4 patents)

bronzeMedal Bo Yu (2 out of 11 patents)

4.  Darlene K Taylor (1 out of 3 patents)

5.  Jean-Marie Soma (1 out of 1 patent)

6.  James H Segars (1 out of 1 patent)

7.  Gregory L Sabatino (1 patent)

8.  Phillip J Bassett (1 patent)

9.  Hazel A Tharia (1 patent)

10.  Antony G Hitchcock (1 patent)

11.  Marie Badalamente (0 patent)

12.  Jr Benjamin J Del Tito (0 patent)

13.  Philip J Bassett (0 patent)

14.  Jr Benjamin J Del Tito (0 patent)


6 patents:

Company Overview
Biospecifics Technologies Corporation is a biopharmaceutical company that specializes in the development of unique protein therapeutics for various medical conditions. Their flagship product, collagenase clostridium histolyticum, is used in the treatment of conditions such as Dupuytren's contracture and Peyronie's disease. With a strong focus on research and development, Biospecifics is dedicated to improving the lives of patients through innovative medical solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#3 in Lynbrook, NY

#2,695 in New York

#44,981 in US

Lynbrook, NY (US)
Lynbrook, NY, United States of America
Forward Citations = 8

6 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biospecifics Technologies Corporation. Retrieved from https://idiyas.com/company/biospecifics-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…